JPRN-UMIN000032339
已完成
4 期
Brexpiprazole for the treatment of acute schizophrenia in the Japanese population - Brexpiprazole for acute schizophrenia
Fujita Health University School of Medicine0 个研究点目标入组 100 人2018年4月21日
概览
- 阶段
- 4 期
- 干预措施
- 未指定
- 疾病 / 适应症
- schizophrenia
- 发起方
- Fujita Health University School of Medicine
- 入组人数
- 100
- 状态
- 已完成
- 最后更新
- 2年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- 未提供
排除标准
- •1\. the patient with coma 2\. the patient receiving anesthetic agent or barbiturate 3\. the patient receiving epinephrine 4\. the patient receiving psychostimulant 5\. the patient having allergy brexpiprazole 6, the patient with DM 7\. the patient with pregnancy 8\. the patient with breast\-feeding 9\. the patient receiving clozapine 10\. the patient suitable for clozapine 11\. the patient who the clinician do not suggest to entry the study 12\. the patient with mental retardation 13\. the patient with dementia 14\. the patient with personality disorder 15\. the patient with organic brain disease and/or severe physical disease 16\. the patient receiving paroxetine 17\. the patient receiving carbamazepine 18\. the patient receiving electroconvulsive therapy within 6 months before the study 19\. the patient receiving long\-acting injectable antipsychotics within 6 months before the study
结局指标
主要结局
未指定
相似试验
已完成
不适用
Aripiprazole research over schizophrenia patients (both on first episode and recurrence) about its efficacy and influence on cognitive functioschizophreniaJPRN-UMIN000002076Kyoto University Hospital20
招募中
不适用
Real-life Assessment of Brexpiprazole (Rexulti) in Schizophrenia and in Depressive DisordersPsychosisDepressionNCT05962216Dr. Albert Kar-Kin Chung40
招募中
4 期
Treatment of Schizophrenia with Aripiprazole. A one year open-label study.SchizophreniaMental Health - SchizophreniaACTRN12605000394640Associate Professor Krishna Vaddadi40
招募中
3 期
Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute SchizophreniaAcute SchizophreniaNCT05325645Otsuka Pharmaceutical Co., Ltd.450
已完成
2 期
A dose-finding trial of OPC-34712 in patients with schizophreniaSchizophreniaJPRN-jRCT2080221591Otsuka Pharmaceutical Co., Ltd.447